DeepMed Research

YALE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1701-10-09

Employees: 10K

Market Cap: -

Website: http://www.yale.edu

Clinical Trials

Spica Cast Duration for DDH

Not Applicable

Not yet recruiting

Conditions: Dysplasia; Hip

Interventions: Device: Spica cast
Device: Rhino brace

First Posted Date: 2024-01-12

Last Posted Date: 2025-03-18

Lead Sponsor: Yale University

Target Recruit Count: 300

Registration Number: NCT06204068

Locations: 🇺🇸
Yale New Haven Hospital, New Haven, Connecticut, United States

Biliary Atresia Research Network Northeast

Recruiting

Conditions: Biliary Atresia

First Posted Date: 2023-12-29

Last Posted Date: 2025-03-07

Lead Sponsor: Yale University

Target Recruit Count: 150

Registration Number: NCT06184971

Locations: 🇺🇸
Connecticut Children's Medical Center, Hartford, Connecticut, United States
🇺🇸
Yale University, New Haven, Connecticut, United States
🇺🇸
Eastern Maine Medical Center, Bangor, Maine, United States

and more 11 locations

Oral Azacitidine (CC-486) Epigenetic Priming and Maintenance for Adult Acute Myeloid Leukemia (AML) Patients

Phase 2

Withdrawn

Conditions: Acute Myeloid Leukemia

Interventions: Drug: oral azacitidine (CC-486)

First Posted Date: 2023-12-26

Last Posted Date: 2023-12-26

Lead Sponsor: Yale University

Registration Number: NCT06180863

Locations: 🇺🇸
Yale Comprehensive Cancer Center, New Haven, Connecticut, United States

Real-World Effectiveness of Perinatal RSV Immunoprophylaxis

Recruiting

Conditions: RSV Infection

Interventions: Drug: Nirsevimab

First Posted Date: 2023-12-15

Last Posted Date: 2024-10-08

Lead Sponsor: Yale University

Target Recruit Count: 3750

Registration Number: NCT06172660

Locations: 🇺🇸
Yale Child Health Research Center, New Haven, Connecticut, United States

Glu-COACH: a Peer-mentoring Intervention to Reduce Disparities in Continuous Glucose Monitor (CGM) Use

Not Applicable

Recruiting

Conditions: Type 1 Diabetes

Interventions: Behavioral: Enhanced standard-of-care (ESOC)
Behavioral: Glu-COACH

First Posted Date: 2023-12-14

Last Posted Date: 2024-07-05

Lead Sponsor: Yale University

Target Recruit Count: 50

Registration Number: NCT06171412

Locations: 🇺🇸
Yale Children's Diabetes Clinic, New Haven, Connecticut, United States

Long Term Follow Up KET-PD

Conditions: Parkinson's Disease
Depression

Interventions: Other: Cognitive Behavior Therapy (CBT)
Other: Treatment As Usual (TAU)

First Posted Date: 2023-12-11

Last Posted Date: 2024-11-12

Lead Sponsor: Yale University

Target Recruit Count: 40

Registration Number: NCT06164756

Locations: 🇺🇸
Yale New Haven Hospital, New Haven, Connecticut, United States

Effect of Chlorhexidine Gluconate Bladder Instillations in Patients With Chronic Suprapubic Catheters on Unplanned Healthcare Encounters and Quality of Life

Not Applicable

Recruiting

Conditions: Neurogenic Bladder
Urinary Retention

Interventions: Device: Bladder instillation with Irrisept

First Posted Date: 2023-12-08

Last Posted Date: 2025-05-13

Lead Sponsor: Yale University

Target Recruit Count: 70

Registration Number: NCT06163469

Locations: 🇺🇸
Yale New Haven Health, New Haven, Connecticut, United States

Exploration of Synaptotrophic Effects of Psilocybin in Opioid Use Disorder (OUD)

Phase 1

Recruiting

Conditions: Opioid Use Disorder

Interventions: Drug: Psilocybin

First Posted Date: 2023-12-07

Last Posted Date: 2025-05-08

Lead Sponsor: Yale University

Target Recruit Count: 12

Registration Number: NCT06160284

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

Transcranial Magnetic Stimulation (TMS) to Treat Depression in Autism Spectrum Disorder

Not Applicable

Recruiting

Conditions: Autism Spectrum Disorder

Interventions: Device: MAGSTIM Rapid2 TMS system

First Posted Date: 2023-11-22

Last Posted Date: 2024-05-23

Lead Sponsor: Yale University

Target Recruit Count: 60

Registration Number: NCT06142955

Locations: 🇺🇸
Yale Psychiatric Hospital, New Haven, Connecticut, United States

Influence of Mavoglurant on Alcohol Craving and Drinking in Heavy Drinkers

Phase 2

Recruiting

Conditions: Alcohol Consumption
Alcohol Use Disorder (AUD)
Heavy Drinker

Interventions: Drug: Mavoglurant

First Posted Date: 2023-11-18

Last Posted Date: 2024-08-15

Lead Sponsor: Yale University

Target Recruit Count: 63

Registration Number: NCT06136195

Locations: 🇺🇸
Connecticut Mental Health Center (SAC and SATU), New Haven, Connecticut, United States
🇺🇸
Yale New Haven Hospital, New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy